skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Therapeutic use of fractionated total body and subtotal body irradiation

Journal Article · · Cancer (Philadelphia); (United States)

Ninety-one patients were treated using fractionated subtotal body (STBI) or total body irradiation (TBI). These patients had generalized lymphomas, Hodgkin's disease, leukemias, myelomas, seminomas, or oat-cell carcinomas. Subtotal body irradiation is delivered to the entire body, except for the skull and extremities. It was expected that a significantly higher radiation dose could be administered with STBI than with TBI. STBI was given when there was a reasonable likelihood that malignancy did not involve the shielded volumes. A five- to ten-fold increase in tolerance for STBI was demonstrated. Many of these patients have had long-term (up to 17 year--.permanent) remissions. There is little or no treatment-induced symptomatology, and no sanctuary sites. STBI and TBI are useful therapeutic modalities for many of these malignancies.

OSTI ID:
5390960
Journal Information:
Cancer (Philadelphia); (United States), Vol. 47:9
Country of Publication:
United States
Language:
English

Similar Records

Therapeutic use of fractionated total body and subtotal body irradiation. [X-rays]
Conference · Fri May 01 00:00:00 EDT 1981 · Cancer; (United States) · OSTI ID:5390960

A phase I study of WR-2721 in combination with total body irradiation (TBI) in patients with refractory lymphoid malignancies
Journal Article · Wed Jan 01 00:00:00 EST 1992 · International Journal of Radiation Oncology, Biology and Physics; (United States) · OSTI ID:5390960

Combined modality therapy of diffuse histology non-Hodgkin's lymphoma with cyclophosphamide, adriamycin, vincristine, prednisone (CHOP) and total body irradiation
Journal Article · Mon Aug 01 00:00:00 EDT 1983 · Int. J. Radiat. Oncol., Biol. Phys.; (United States) · OSTI ID:5390960